人类白血球抗原吻合系统（HLA）的发现促成1968年成功完成全球首例组织型完全吻合( HLA-matched)的血缘异体骨髓移植(6)，初时应用于先天免疫缺乏症病人，后更扩及严重再生不良性贫血及白血病患者，以后更发现异体骨髓移植前先予...
基于16个网页-相关网页
unrelated hla-matched donor 非亲缘hla相合供者
hla matched hla相合
HLA-matched sibliny HLA相合同胞
partially HLA-matched HLA部分相合
unrelated HLA phenotypically matched donor HLA表型相合的无血缘供者
All available data suggest that UCBT should be carried out for the patients who require an urgent transplantation but lacking an HLA-matched BM donor.
目前的数据显示，因为HLA配型等原因而无法进行骨髓移植的患者应该尽早进行UCBT。
However, when allogeneic organ transplantation is performed, the biggest barrier to be overcomed is to select a suitable donor whose HLA is fully matched with the recipient.
然而在进行异基因脏器移植时，首先遇到的最大障碍就是难以寻找到一个白细胞抗原(HLA)完全相匹配的适宜供体。
The first-choice treatment for aplastic anemia is bone marrow transplant with a sibling donor who is human lymphocyte antigens (HLA) matched.
再障的首选治疗是人淋巴细胞抗原相配的同胞姊妹骨髓移植。
应用推荐